← Evidence map

ArticleCurrent pharmaceutical design2021

Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients.

Kholoud F Aliter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33001004